Production (Stage)
Caribou Biosciences, Inc.
CRBU
$1.18
$0.065.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 208.47M | 209.54M | 228.18M | 261.65M | 293.99M |
| Total Receivables | 2.74M | 3.25M | 2.67M | 2.92M | 3.61M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.86M | 4.81M | 4.38M | 3.93M | 5.07M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.26M | 1.78M | 2.20M | 2.38M | 1.85M |
| Total Current Assets | 217.32M | 219.38M | 237.43M | 270.88M | 304.51M |
|
|
|||||
| Total Current Assets | 217.32M | 219.38M | 237.43M | 270.88M | 304.51M |
| Net Property, Plant & Equipment | 38.04M | 39.29M | 40.06M | 41.01M | 40.83M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.04M | 5.52M | 4.74M | 1.64M | 1.79M |
| Total Assets | 273.66M | 313.31M | 344.33M | 372.94M | 406.83M |
|
|
|||||
| Total Accounts Payable | 3.87M | 2.48M | 2.70M | 3.23M | 5.94M |
| Total Accrued Expenses | 18.34M | 21.94M | 20.56M | 21.51M | 17.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.90M | 1.43M | 1.18M | 1.26M | 1.26M |
| Total Finance Division Other Current Liabilities | 4.37M | 4.81M | 7.72M | 4.95M | 4.55M |
| Total Other Current Liabilities | 4.37M | 4.81M | 7.72M | 4.95M | 4.55M |
| Total Current Liabilities | 28.49M | 30.65M | 32.16M | 30.94M | 29.02M |
|
|
|||||
| Total Current Liabilities | 28.49M | 30.65M | 32.16M | 30.94M | 29.02M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 24.32M | 25.06M | 25.46M | 25.53M | 25.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.62M | 4.65M | 5.51M | 6.00M | 8.62M |
| Total Liabilities | 56.43M | 60.36M | 63.13M | 62.47M | 63.54M |
|
|
|||||
| Common Stock & APIC | 705.44M | 701.09M | 693.31M | 689.00M | 684.13M |
| Retained Earnings | -488.38M | -448.39M | -412.90M | -378.22M | -340.52M |
| Treasury Stock & Other | 167.00K | 255.00K | 789.00K | -319.00K | -322.00K |
| Total Common Equity | 217.22M | 252.95M | 281.20M | 310.46M | 343.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 217.22M | 252.95M | 281.20M | 310.46M | 343.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 217.22M | 252.95M | 281.20M | 310.46M | 343.29M |
|
|
|||||